Prescott Group Urges PharmAthene Shareholders to Vote Down Proposed Theraclone Merger
November 27, 2013 at 07:03 AM EST
Prescott Group Capital Management, a greater than 10% shareholder of PharmAthene (NYSE: PIP ), urges all stockholders to vote AGAINST the issuance of shares needed to complete the proposed merger with
